Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oramed Pharmaceuticals (ORMP) Return on Equity (2022 - 2025)

Oramed Pharmaceuticals (ORMP) has disclosed Return on Equity for 3 consecutive years, with 0.03% as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Return on Equity rose 19.0% year-over-year to 0.03%, compared with a TTM value of 0.03% through Sep 2024, up 19.0%, and an annual FY2023 reading of 0.03%, changed N/A over the prior year.
  • Return on Equity was 0.03% for Q3 2024 at Oramed Pharmaceuticals, down from 0.12% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.12% in Q2 2024 and bottomed at 0.28% in Q4 2022.
  • Average Return on Equity over 3 years is 0.08%, with a median of 0.08% recorded in 2023.
  • Peak annual rise in Return on Equity hit 31bps in 2024, while the deepest fall reached 19bps in 2024.
  • Year by year, Return on Equity stood at 0.28% in 2022, then skyrocketed by 102bps to 0.01% in 2023, then soared by 307bps to 0.03% in 2024.
  • Business Quant data shows Return on Equity for ORMP at 0.03% in Q3 2024, 0.12% in Q2 2024, and 0.05% in Q1 2024.